18 reports

CytoSorb: Extracorporeal Cytokine Adsorber

  • Clinical Trial
  • World
  • United States
  • Direct Sales
  • Drug Approval

■ In June 2020, CytoSorbents Corporation announced the commercial launch and immediate availability of CytoSorb (extracorporeal cytokine adsorber) in Argentina.

  • Protein Therapy
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Cancer Incidence
  • Health Expenditure

CytoSorb is the product approved by European Union which is used as extracorporeal cytokine adsorber.

  • Hemodialysis Device
  • Urology
  • Medical Device
  • APAC
  • World
  • Health Expenditure
  • Medical Devices Sales

The objective of the study is to investigate the effects of CytoSorb i.e., an extracorporeal cytokine adsorber in cardiopulmonary bypass during orthotopic heart transplantation.

  • Clinical Trial
  • Massachusetts
  • South Africa
  • Suffolk County
  • Mortality Rate
  • Direct Sales

The objective of the study is to investigate the effects of CytoSorb i.e., an extracorporeal cytokine adsorber in cardiopulmonary bypass during orthotopic heart transplantation.

  • Clinical Trial
  • Massachusetts
  • South Africa
  • Suffolk County
  • Mortality Rate
  • Direct Sales

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Clinical Trial
  • Massachusetts
  • Suffolk County
  • Direct Sales
  • Hospital Admission

In the report, "Recommendations for the management of hemophagocytic lymphohistiocytosis in adults", current members of the working group "HLH in Adults" of the Histiocyte Society published guideline recommendations based on expert opinion supported by the best available evidence from studies supporting the individual statements on the treatment of HLH. Citing specific case evidence on the CytoSorb extracorporeal cytokine adsorber in the guidelines on salvage treatment of relapsed and refractory HLH, authors state, "the use of cytokine adsorption columns may aid in rescuing critically ill patients from a deleterious cytokine storm."

  • Prosthesis
  • North America
  • Canada
  • Mexico
  • Drug Approval
  • Direct Sales

In the report, "Recommendations for the management of hemophagocytic lymphohistiocytosis in adults", current members of the working group "HLH in Adults" of the Histiocyte Society published guideline recommendations based on expert opinion supported by the best available evidence from studies supporting the individual statements on the treatment of HLH. Citing specific case evidence on the CytoSorb extracorporeal cytokine adsorber in the guidelines on salvage treatment of relapsed and refractory HLH, authors state, "the use of cytokine adsorption columns may aid in rescuing critically ill patients from a deleterious cytokine storm."

  • Prosthesis
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Direct Sales
  • Drug Approval

In the report, "Recommendations for the management of hemophagocytic lymphohistiocytosis in adults", current members of the working group "HLH in Adults" of the Histiocyte Society published guideline recommendations based on expert opinion supported by the best available evidence from studies supporting the individual statements on the treatment of HLH. Citing specific case evidence on the CytoSorb extracorporeal cytokine

  • Prosthesis
  • United Kingdom
  • Direct Sales
  • Drug Approval

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Medical Equipment
  • Pennsylvania
  • Direct Sales
  • Drug Approval

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Pharmaceutical
  • Healthcare
  • United States
  • World
  • Direct Sales
  • Drug Approval

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Managed Care
  • Pharmaceutical
  • Private Placement
  • Renal Disease
  • World
  • India
  • Outpatient Facility Number
  • Pharmaceutical Production

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Renal Disease
  • United States
  • APAC
  • North America
  • Medical Facilities Revenue
  • Drug Approval

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Medical Equipment
  • United States
  • Lighting Production
  • Direct Sales

Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins.

  • Pharmaceutical
  • Insulin
  • Healthcare
  • India
  • Foreign Direct Investment
  • Prescription Drug Sales

In the report, "Recommendations for the management of hemophagocytic lymphohistiocytosis in adults", current members of the working group "HLH in Adults" of the Histiocyte Society published guideline recommendations based on expert opinion supported by the best available evidence from studies supporting the individual statements on the treatment of HLH. Citing specific case evidence on the CytoSorb extracorporeal cytokine adsorber in the guidelines on salvage treatment of relapsed and refractory HLH, authors state, "the use of cytokine adsorption columns may aid in rescuing critically ill patients from a deleterious cytokine storm."

  • Medical Device
  • Cardiovascular Devices
  • Prosthesis
  • Peripheral Vascular Device
  • United Kingdom
  • Medical Technology Density
  • Direct Sales

cytokine

  • Urology
  • Therapy
  • Europe
  • APAC
  • World
  • Mortality Rate
  • Diabetes Prevalence

CytoSorbents Corporation, manufacturer of the CytoSorb® extracorporeal cytokine adsorber that targets the reduction of excessive inflammatory mediators in critically-ill and cardiac surgery patients, announced that the company and its strategic partner, Terumo Cardiovascular Group, have initiated international marketing of CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) conference in Barcelona, Spain (October ##-##).

  • Injectable Delivery
  • Drug Delivery
  • Spain
  • Direct Sales
  • Medical Supply Sales